Life Sciences & Pharma A Bifurcated Lab Market Is Reshaping Strategic Priorities and Capital Decisions February 27, 2026
MedTech Reinventing Value Creation in Medtech CDMO: A Smarter Playbook for PE Exits February 26, 2026
Financial Services P&C Commercial Lines Distribution Reinvented: Why Legacy Strategies Won’t Win the Next Cycle February 03, 2026
Healthcare Services Unlocking Deal Value: How Operational Due Diligence Shapes a Feasible, High-Impact Value Creation Strategy January 12, 2026